Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Agios Pharmaceuticals Inc shares valued at $9,256 were sold by Scadden David on Dec 11 ’24. At $46.28 per share, Scadden David sold 200 shares. The insider’s holdings dropped to 15,483 shares worth approximately $0.53 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Washburn Theodore James Jr. sold 772 shares, netting a total of over 43,301 in proceeds. Following the sale of shares at $56.09 each, the insider now holds 813 shares.
Before that, Ballal Rahul D. had sold 10,000 shares from its account. In a trade valued at $581,911, the Director traded Agios Pharmaceuticals Inc shares for $58.19 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.27 million.
As published in their initiating research note from Scotiabank on October 16, 2024, Agios Pharmaceuticals Inc [AGIO] has been a Sector outperform. As of September 27, 2024, Leerink Partners has decreased its “an Outperform” rating to a “Market perform” for AGIO. Earlier on February 08, 2024, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for AGIO stock.
Analyzing AGIO Stock Performance
During the last five days, there has been a drop of approximately -11.92%. Over the course of the year, Agios Pharmaceuticals Inc shares have jumped approximately 54.33%. Shares of the company reached a 52-week high of $62.58 on 11/11/24 and a 52-week low of $20.96 on 01/19/24. A 50-day SMA is recorded $49.03, while a 200-day SMA reached $42.22. Nevertheless, trading volume fell to 0.66 million shares from 0.79 million shares the previous day.
Support And Resistance Levels for Agios Pharmaceuticals Inc (AGIO)
According to the 24-hour chart, there is a support level at 33.78, which, if violated, would cause prices to drop to 33.18. In the upper region, resistance lies at 34.94. The next price resistance is at 35.50. RSI (Relative Strength Index) is 27.98 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -6.48, which suggests the price will decrease in the coming days. Percent R is at 97.84%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
